Neurocrine biosciences appoints dr. sanjay keswani as chief medical officer

Accomplished physician-scientist brings more than 20 years of industry leadership experience and broad r&d expertise in multiple therapeutic areas  san diego , april 4, 2025 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) today announced the appointment of sanjay keswani, m.d., to the company's executive management team as chief medical officer (cmo) effective june 2, 2025.
NBIX Ratings Summary
NBIX Quant Ranking